The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein-Protein Interactions

被引:52
|
作者
Toure, B. Barry [1 ]
Miller-Moslin, Karen [1 ]
Yusuff, Naeem [1 ]
Perez, Lawrence [1 ]
Dore, Michael [1 ]
Joud, Carol [1 ]
Michael, Walter [1 ]
DiPietro, Lucian [1 ]
van der Plas, Simon [1 ]
McEwan, Michael [1 ]
Lenoir, Francois [1 ]
Hoe, Madelene [1 ]
Karki, Rajesh [1 ]
Springer, Clayton [1 ]
Sullivan, John [1 ]
Levine, Kymberly [1 ]
Fiorilla, Catherine [1 ]
Xie, Xiaoling [1 ]
Kulathila, Raviraj [1 ]
Herlihy, Kara [1 ]
Porter, Dale [1 ]
Visser, Michael [1 ]
机构
[1] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 02期
关键词
B cell lymphoma; Bcl-2; family; protein-protein interaction; apoptosis; cancer; DISCOVERY; ANTAGONISTS; PRODRUGS;
D O I
10.1021/ml300321d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Overexpression of the antiapoptotic members of the Bcl-2 family of proteins is commonly associated with cancer cell survival and resistance to chemotherapeutics. Here, we describe the structure-based optimization of a series of N-heteroaryl sulfonamides that demonstrate potent mechanism-based cell death. The role of the acidic nature of the sulfonamide moiety as it relates to potency, solubility, and clearance is examined. This has led to the discovery of novel heterocyclic replacements for the acylsulfonamide core of ABT-737 and ABT-263.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 50 条
  • [21] The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family
    H M Heath-Engel
    N C Chang
    G C Shore
    Oncogene, 2008, 27 : 6419 - 6433
  • [22] THE ROLE OF THE BCL-2 PROTEIN FAMILY TN TUMORIGENESIS AND CANCER THERAPY
    Strasser, Andreas
    Kelly, G.
    Glaser, S.
    Kelly, P. N.
    Grabow, S.
    Delbridge, A.
    Herold, M.
    Adams, J. M.
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S9 - S9
  • [23] Bcl-2 protein family: Localization and translocation
    Zhou, ZP
    Liu, SS
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (05) : 650 - 653
  • [24] Elucidating specificity determinants in Bcl-2 family protein-peptide interactions
    Keating, Amy E.
    Dutta, Sanjib
    Gulla, Stefano
    Chen, T. C. Scott
    Fire, Emiko
    Grant, Robert A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [25] A small molecule inhibitor of BCL-2 protein-protein interactions specifically induces apoptosis in cancer cells.
    Murthy, MS
    Steenaart, NA
    Watson, MH
    Chen, G
    Babineau, A
    Beauparlant, P
    Shore, GC
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3717S - 3717S
  • [26] Bcl-B: an “unknown” protein of the Bcl-2 family
    N. V. Pervushin
    G. S. Kopeina
    B. Zhivotovsky
    Biology Direct, 18
  • [27] Bcl-B: an "unknown" protein of the Bcl-2 family
    Pervushin, N. V.
    Kopeina, G. S.
    Zhivotovsky, B.
    BIOLOGY DIRECT, 2023, 18 (01)
  • [28] RNA Polymerase Tags To Monitor Multidimensional Protein-Protein Interactions Reveal Pharmacological Engagement of Bcl-2 Proteins
    Pu, Jinyue
    Dewey, Jeffrey A.
    Hadji, Abbas
    LaBelle, James L.
    Dickinson, Bryan C.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2017, 139 (34) : 11964 - 11972
  • [29] Molecular Docking-assisted Protein Chip Screening of Inhibitors for Bcl-2 Family Protein-protein Interaction to Discover Anticancer Agents by Fragment-based Approach
    Yoou, Myoung-Schook
    Cho, Sungjoon
    Choi, Youngjin
    BIOCHIP JOURNAL, 2019, 13 (03) : 260 - 268
  • [30] Molecular Docking-assisted Protein Chip Screening of Inhibitors for Bcl-2 Family Protein-protein Interaction to Discover Anticancer Agents by Fragment-based Approach
    Myoung-Schook Yoou
    Sungjoon Cho
    Youngjin Choi
    BioChip Journal, 2019, 13 : 260 - 268